Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carl Graham and Jonathan Edgeworth.
Carl Graham
Connection Strength
0.630
Jonathan Edgeworth
  1. Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave. PLoS One. 2021; 16(4):e0249791.
    View in: PubMed
    Score: 0.235
  2. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings. PLoS Pathog. 2020 09; 16(9):e1008817.
    View in: PubMed
    Score: 0.226
  3. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020 12; 5(12):1598-1607.
    View in: PubMed
    Score: 0.057
  4. Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 Oct; 26(10):1663.
    View in: PubMed
    Score: 0.057
  5. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 10; 26(10):1623-1635.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.